Variant report
Variant | nsv878809 |
---|---|
Chromosome Location | chr4:30652196-30676425 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:30657308..30659820-chr4:30660104..30662010,2 | MCF-7 | breast: | |
2 | chr4:30657504..30660121-chr4:30665099..30668575,3 | MCF-7 | breast: | |
3 | chr4:30657308..30659820-chr4:30660104..30662010,2 | MCF-7 | breast: | |
4 | chr4:30657504..30660121-chr4:30665099..30668575,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574330221 | chr4:30654603-30654604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186712580 | chr4:30654659-30654660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563269724 | chr4:30654664-30654665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536456585 | chr4:30654678-30654679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545845706 | chr4:30654713-30654714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368464508 | chr4:30654717-30654718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1486784 | chr4:30654746-30654747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555109531 | chr4:30654772-30654773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548432009 | chr4:30654773-30654774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561432452 | chr4:30654776-30654777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138009727 | chr4:30654805-30654806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191557920 | chr4:30654808-30654809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73814404 | chr4:30654904-30654905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529559960 | chr4:30654914-30654915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551275383 | chr4:30654937-30654938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149514065 | chr4:30654970-30654971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183687269 | chr4:30654971-30654972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368790363 | chr4:30654987-30654988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187003245 | chr4:30655004-30655005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376588671 | chr4:30655022-30655023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191086084 | chr4:30655036-30655037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182162542 | chr4:30655059-30655060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372200284 | chr4:30655078-30655079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3103048 | chr4:30655104-30655105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77685948 | chr4:30655142-30655143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535298983 | chr4:30655161-30655162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549324627 | chr4:30655237-30655238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144112770 | chr4:30655268-30655269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575423529 | chr4:30655284-30655285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148684491 | chr4:30655285-30655286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs36061926 | chr4:30655294-30655295 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs573230085 | chr4:30655344-30655345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573222685 | chr4:30655347-30655348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75054210 | chr4:30655385-30655386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552266337 | chr4:30655405-30655406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529420598 | chr4:30655413-30655414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544791676 | chr4:30655442-30655443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545999657 | chr4:30655519-30655520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147349349 | chr4:30655537-30655538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533418169 | chr4:30655586-30655587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552088678 | chr4:30655596-30655597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145078854 | chr4:30655619-30655620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528101938 | chr4:30655627-30655628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150959321 | chr4:30655644-30655645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552421170 | chr4:30655667-30655668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567782946 | chr4:30655733-30655734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535197783 | chr4:30655742-30655743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371596828 | chr4:30655744-30655745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186703336 | chr4:30655781-30655782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191555248 | chr4:30655790-30655791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:30654600-30657000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr4:30656800-30657200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr4:30663000-30665400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:30663200-30663600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr4:30663600-30664000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr4:30664000-30664200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr4:30664200-30665000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:30665000-30665200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr4:30665200-30667600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr4:30667400-30668200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr4:30667800-30668000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr4:30668200-30668400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr4:30668400-30669200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr4:30669400-30669600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr4:30671800-30672400 | Enhancers | Fetal Lung | lung |
16 | chr4:30673400-30674400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |